| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.013 | 0.8 |